首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Pharmacogenomics journal

缩写:PHARMACOGENOMICS J

ISSN:1470-269X

e-ISSN:1473-1150

IF/分区:2.9/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引1106
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
D Naidoo,A C Wu,M H Brilliant et al. D Naidoo et al.
Several reports have shown that statin treatment benefits patients with asthma; however, inconsistent effects have been observed. The mir-152 family (148a, 148b and 152) has been implicated in asthma. These microRNAs suppress HLA-G expressi...
A Gézsi,O Lautner-Csorba,D J Erdélyi et al. A Gézsi et al.
CYP3A4 has an important role in the metabolisms of many drugs used in acute lymphoblastic leukemia (ALL) therapy; still, there are practically no publications about the role of CYP3A4 polymorphisms in ALL pharmacogenomics. We genotyped eigh...
V Chidambaran,J Mavi,H Esslinger et al. V Chidambaran et al.
The μ1 opioid receptor (OPRM1) genetic variant A118G results in decreased μ-receptor binding potential in the brain and increases morphine requirement. We hypothesized that OPRM1 A118G polymorphism will affect morphine-induced respiratory...
C Gamero-Villarroel,L María González,I Gordillo et al. C Gamero-Villarroel et al.
Genetics variants in the NEGR1 gene, strongly expressed in the brain, have been reported to affect the neuronal control of food intake therefore inducing obesity. With the same rationale, we hypothesized that this genetic variability may be...
L Karlsson,A-L Zackrisson,M Josefsson et al. L Karlsson et al.
We investigated whether polymorphisms in the CYP2D6 and CYP2C19 genes influence the metabolic ratios and enantiomeric S/R ratios of venlafaxine (VEN) and its metabolites O-desmethylvenlafaxine (ODV), N-desmethylvenlafaxine (NDV) and N,O-did...
Q Zheng,H Wu,Q Yu et al. Q Zheng et al.
Imatinib mesylate, a competitive tyrosine kinase inhibitor, is considered the first-line therapy drug for Ph+ chronic myeloid leukemia (CML). Three single-nucleotide polymorphisms (SNPs) in the ATP-binding cassette, subfamily B (MDR/TAP), m...
C Wang,H Zheng,J-W He et al. C Wang et al.
Alendronate is an antiosteoporotic drug that targets the mevalonate pathway. To investigate whether the genetic variations in this pathway affect the clinical efficacy of alendronate in postmenopausal Chinese women with osteopenia or osteop...
L Rojas,I Neumann,M José Herrero et al. L Rojas et al.
The highly variable pharmacokinetics of tacrolimus can hamper the optimal management of kidney transplant patients. This variability has been attributed to the genetic polymorphism of CYP3A5 6986A>G, but the evidence is not clear. We conduc...
J L Del-Aguila,R M Cooper-DeHoff,A B Chapman et al. J L Del-Aguila et al.
Hypokalemia is a recognized adverse effect of thiazide diuretic treatment. This phenomenon, which may impair insulin secretion, has been suggested to be a reason for the adverse effects on glucose metabolism associated with thiazide diureti...
R Cascella,C Strafella,M Ragazzo et al. R Cascella et al.
One of the most successful applications of pharmacogenetics research is the genetic screening for HLA-B*57:01, strongly associated with an increased risk to develop hypersensitivity reaction in HIV-positive patients following abacavir admin...